Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 2, 2010, Pages 211-217

  Jiang, Lei ^a   Bao, Yi ^a   Luo, Chun ^a   Hu, Guohan ^a   Huang, Chengguang ^a   Ding, Xuehua ^a   Sun, Kehua ^a   Lu, Yicheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Glioma; Proliferation; UbcH10

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2C; UNCLASSIFIED DRUG; UBE2C PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME;

APOPTOSIS; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; GLIOMA; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MITOSIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA INTERFERENCE; WESTERN BLOTTING; CELL CYCLE; CENTRAL NERVOUS SYSTEM TUMOR; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; RNA INTERFERENCE; UBIQUITIN-CONJUGATING ENZYMES;

EID: 74049128005     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0651-z     Document Type: Article

References (21)

1. Berlingieri MT, Pallante P, Sboner A et al (2007a) UbcH10 is overexpressed in malignant breast carcinomas. Eur J Cancer 43:2729-2735.
2. Berlingieri MT, Pallante P, Guida M et al (2007b) UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene 26:2136-2140.
3. El-Deiry WS (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8:345-357.
4. Ieta K, Ojima E, Tanaka F et al (2007) IdentiWcation of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer 121:33-38.
5. Jiang L, Huang CG, Lu YC et al (2008) Expression of ubiquitinconjugating enzyme E2C/UbcH10 in astrocytic tumors. Brain Res 27:161-166.
6. King RW, Deshaies RJ, Peters JM, Kirschner MW (1996) How proteolysis drives the cell cycle. Science 274:1652-1659.
7. Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225.
8. Lin Y, Hwang WC, Basavappa R (2002) Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10. J Biol Chem 277:21913-21921.
9. Lin J, Raoof DA, Wang Z et al (2006) Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia 8:1062-1071.
10. Midgley CA, Desterro JM, Saville MK et al (2000) An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19:2312-2323.
11. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, Nakagawara A (2003) UbcH10 is the cancer-related E2 ubiquitinconjugating enzyme. Cancer Res 63:4167-4173.
12. Pallante P, Berlingieri MT, Troncone G et al (2005) UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 93:464-471.
13. Rape M, Reddy SK, Kirschner MW (2006) The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124:89-103.
14. Reddy SK, Rape M, Margansky WA, Kirschner MW (2007) Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446:921-925.
15. Skibbens RV, Hieter P (1998) Kinetochores and the checkpoint mechanism that monitors for defects in the chromosome segregation machinery. Annu Rev Genet 32:307-337.
16. Smits VA, Medema RH (2001) Checking out the G(2)/M transition. Biochim Biophys Acta 1519:1-12.
17. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803-1815.
18. Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV (1997) Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci USA 94:2362-2367.
19. Vassilev LT, Vu BT, Graves B et al (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848.
20. Wagner KW, Sapinoso LM, El-Rifai W et al (2004) Overexpression, genomic ampliWcation and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 23:6621-6629.
21. Wang W, El-Deiry WS (2008) Restoration of p53 to limit tumor growth. Curr Opin Oncol 20:90-96.